Form D — Caldera Therapeutics, Inc.
0002069936-26-000001 · filed Jan 21, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $37,500,000
- Reported amount sold
- $37,500,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Caldera Therapeutics, Inc.
- CIK
- 2069936
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2025
- Address
- 300 TECHNOLOGY SQUARE
CAMBRIDGE, Massachusetts 02139 - Phone
- (781) 254-6624
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Praveen Tipirneni · Executive OfficerCambridge, Massachusetts Find on LinkedIn ↗
-
Michael Gladstone · DirectorCambridge, Massachusetts Find on LinkedIn ↗
-
Aaron Royston · DirectorCambridge, Massachusetts Find on LinkedIn ↗
-
Xiaodi Su · DirectorCambridge, Massachusetts Find on LinkedIn ↗
-
Michelle Doig · DirectorCambridge, Massachusetts Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗